RSS

vaccines

FLUAD.jpg

Jon Bradley Photography Ltd

Vaccine provider Seqirus has started on-time shipping of its portfolio of Fluad (aTiv), Flucelvax Tetra (QIVc) vaccines to healthcare professionals across the UK. Read more

News

Dr Neil Polwart, Novarum founder and BBI Group head of Mobile, discusses the role technology plays in stopping preventable diseases spreading across the world. Read more

Opinion

Hard-to-reach locations could see temperature-controlled medicines and vaccines being delivered by drones thanks to a project led by humanitarian aid organisation Direct Relief. Read more

News

A pharma technology company has received a $14.3 million grant from the Bill & Melinda Gates Foundation to help increase the availability of measles and rubella (M&R) vaccines in low-and middle-income countries (LMICs). Read more

News

EPM editor Reece Armstrong writes why international efforts are essential for global health concerns like AMR and vaccination. Read more

Opinion

Technology could play a major role in helping to increase adult vaccination rates and break down other barriers to vaccination, according to a new report. Read more

News

Social media is a main driver for propagating negative connotations about vaccinations, according to a new report by the Royal Society for Public Health (RSPH). Read more

News

A pioneering UK vaccine centre dedicated to tackling deadly diseases such as Ebola is to be built in Oxford, the government has announced. Read more

News

A decision by Public Health England to not publish the results of three clinical trials into vaccines for children has been criticised by scientist Read more

News

A record high in the number of cases of measles in the European Region has been revealed by the World Health Organisation (WHO), leading to calls for immediate action to stop the further spread of the disease. Read more

News

Biotechnology company, BioNTech, has entered into a multi-year research and development (R&D) collaboration with Pfizer for the development of mRNA-based vaccines for the prevention of influenza (flu). Read more

News

Manufacturer of egg-based influenza vaccines in the UK, Seqirus, has revealed it is joining the Human Vaccines Project’s Universal Influenza Vaccine Initiative (UIVI) — a collaborative effort to accelerate the development of a universal flu vaccine Read more

News

The UK’s technology innovation provider for process manufacturing, the Centre for Process Innovation (CPI), has announced its involvement in the development of a new research hub aimed at delivering high-quality vaccines at low cost to tackle the spr Read more

News

Emergex Vaccines Holding (Emergex) — a biotechnology company — has been awarded with a grant of £979,318 from Innovate UK to progress its universal flu vaccine programme through preclinical development. Read more

News

Wacker Chemie has acquired a Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines, from SynCo Bio Luxembourg, doubling Wacker Biotech’s overall capacity and strengthening the company’s pharma-protein business Read more

News

In this online exclusive, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), looks at the importance of vaccines in the fight against antimicrobial resistance (AMR). Read more

Opinion

We speak with the CEO of Controlant, Gisli Herjolfsson, about the company and its cold chain solutions that are revolutionising delivery of vaccines to developing countries and more. Read more

Opinion

UK-based synthetic biology company, Prokarium, has completed an investment round, raising $10 million for the clinical development of vaccines against chlamydia, C.difficile and enteric fever, plus an expansion for the immune-oncology R&D team Read more

News

The World Health Organisation (WHO) has released figures highlighting a startling 400% increase in cases of measles reported in 2017 compared with the previous year’s figures. Read more

Analysis

Through identifying the way skin reacts to pathogens in older patients, a team of researchers from University College London (UCL) have found that blocking inflammation may help improve vaccine efficacy. Read more

News